Biomarkers for gastric cancer: Progression in early diagnosis and prognosis

被引：90
作者：
Jin, Ziliang [1 ]
Jiang, Weihua [1 ]
Wang, Liwei [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Oncol, Shanghai Key Lab Pancreat Dis, Shanghai 200080, Peoples R China
来源：
ONCOLOGY LETTERS | 2015年 / 9卷 / 04期
基金：
中国国家自然科学基金;
关键词：
gastric cancer; early diagnosis; prognosis; biological marker; GROWTH-FACTOR RECEPTORS; POOR-PROGNOSIS; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; EPIGENETIC ALTERATION; POTENTIAL BIOMARKERS; CLINICAL-IMPLICATION; SERUM INTERLEUKIN-6; CELL-PROLIFERATION; GENE POLYMORPHISMS;
D O I：
10.3892/ol.2015.2959
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gastric cancer is one of leading causes of cancer-related mortality worldwide and is a notable disease due to its heterogeneity. Recently, numerous studies have investigated the molecular basis of gastric cancer, involving the alteration of pathogenesis, and invasion and metastasis. With the development of modern technologies, various novel biomarkers had been identified that appear to possess diagnostic and prognostic value; therefore, the present review describes our current knowledge of biomarkers for the early diagnosis and prognosis of gastric cancer. Classic biomarkers for gastric cancer diagnosis include carcinoembryonic antigen and cancer antigen 19-9, while microRNA and DNA hypomethylation are proposed as novel biomarkers. Excluding classical biomarkers, biomarkers for determining the progression and prognosis of gastric cancer focus on targeting microRNAs, epigenetic alterations and genetic polymorphisms.
引用
收藏
页码：1502 / 1508
页数：7
相关论文
共 116 条
  • [91] Tenderenda M, 2005, J EXP CLIN CANC RES, V24, P405
  • [92] Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
    Terashima, Masanori
    Kitada, Koji
    Ochiai, Atsushi
    Ichikawa, Wataru
    Kurahashi, Issei
    Sakuramoto, Shinichi
    Katai, Hitoshi
    Sano, Takeshi
    Imamura, Hiroshi
    Sasako, Mitsuru
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5992 - 6000
  • [93] Association Between the FAS/FASL Polymorphisms and Gastric Cancer Risk: A Meta-Analysis
    Tian, Jing
    Pan, Feng
    Li, Jing
    Ma, Yan
    Cen, Han
    Pan, Hai-Feng
    Pan, Yue-Yin
    Ye, Dong-Qing
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (03) : 945 - 951
  • [94] MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3ζ
    Tsukamoto, Yoshiyuki
    Nakada, Chisato
    Noguchi, Tsuyoshi
    Tanigawa, Masato
    Lam Tung Nguyen
    Uchida, Tomohisa
    Hijiya, Naoki
    Matsuura, Keiko
    Fujioka, Toshio
    Seto, Masao
    Moriyama, Masatsugu
    [J]. CANCER RESEARCH, 2010, 70 (06) : 2339 - 2349
  • [95] Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
    Ueda, Tetsuya
    Volinia, Stefano
    Okumura, Hiroshi
    Shimizu, Masayoshi
    Taccioli, Cristian
    Rossi, Simona
    Alder, Hansjuerg
    Liu, Chang-gong
    Oue, Naohide
    Yasui, Wataru
    Yoshida, Kazuhiro
    Sasaki, Hiroki
    Nomura, Sachiyo
    Seto, Yasuyuki
    Kaminishi, Michio
    Calin, George A.
    Croce, Carlo M.
    [J]. LANCET ONCOLOGY, 2010, 11 (02) : 136 - 146
  • [96] Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
    Valladares-Ayerbes, Manuel
    Reboredo, Margarita
    Medina-Villaamil, Vanessa
    Iglesias-Diaz, Pilar
    Jose Lorenzo-Patino, Maria
    Haz, Mar
    Santamarina, Isabel
    Blanco, Moises
    Fernandez-Tajes, Juan
    Quindos, Maria
    Carral, Alberto
    Figueroa, Angelica
    Miguel Anton-Aparicio, Luis
    Calvo, Lourdes
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [97] Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK
    Wang, Ming
    Li, Chenglong
    Nie, Hui
    Lv, Xin
    Qu, Ying
    Yu, Beiqin
    Su, Liping
    Li, Jianfang
    Chen, Xuehua
    Ju, Jingfang
    Yu, Yingyan
    Yan, Min
    Gu, Qinlong
    Zhu, Zhenggang
    Liu, Bingya
    [J]. FEBS LETTERS, 2012, 586 (16) : 2382 - 2388
  • [98] Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy
    Wang, Shizhi
    Chen, Lulu
    Zhao, Qinghong
    Rong, Huan
    Wang, Meilin
    Gong, Weida
    Zhou, Jianwei
    Wu, Dongmei
    Zhang, Zhengdong
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1073 - 1082
  • [99] S100A6 Overexpression Is Associated with Poor Prognosis and Is Epigenetically Up-Regulated in Gastric Cancer
    Wang, Xiao-Hong
    Zhang, Lian-Hai
    Zhong, Xi-Yao
    Xing, Xiao-Fang
    Liu, Yi-Qiang
    Niu, Zhao-Jian
    Peng, Yong
    Du, Hong
    Zhang, Gui-Guo
    Hu, Ying
    Liu, Ni
    Zhu, Yu-Bing
    Ge, Shao-Hua
    Zhao, Wei
    Lu, Ai-Ping
    Li, Ji-You
    Ji, Jia-Fu
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (02) : 586 - 597
  • [100] Promoter Methylation Status of DNA Repair Gene (hMLH1) in Gastric Carcinoma Patients of the Kashmir Valley
    Wani, Majid
    Afroze, Dil
    Makhdoomi, Muzamil
    Hamid, Iqra
    Wani, Bilal
    Bhat, Gulzar
    Wani, Rauf
    Wani, Khursheed
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 4177 - 4181
3456789101112